🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will assess the efficacy and safety of secukinumab in patients w...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-10
Trial ID
NCT01358175
Treatments Being Tested
The study will assess the safety and efficacy of intravenous (10mg/kg) and ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-12
Trial ID
NCT01412944
Treatments Being Tested
Psoriasis is a chronic inflammatory skin disease characterized by scaly ind...
Status
Completed
Location
South Valley Hospitals
Start Date
2024-12-01
Trial ID
NCT06729463
Treatments Being Tested
The purpose of this study is to provide 24 - 52 week efficacy, safety and t...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-04-10
Trial ID
NCT01989468
Treatments Being Tested
The aim of this study is to assess the safety of secukinumab in Indian adul...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-30
Trial ID
NCT07737730
This was a study estimating the clinical difference between 300 mg and 150 ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-03-13
Trial ID
NCT03350815
The goal of this Phase 3 clinical trial is to compare efficacy and safety o...
Status
Active Not Recruiting
Location
Rheumatology Clinic NZOZ Lecznica MAK-MED s.c.
Start Date
2025-05-26
Trial ID
NCT06630559
Treatments Being Tested
Axial spondyloarthritis (axSpA) is a chronic inflammatory disease character...
Status
Completed
Location
CHU d'Angers
Start Date
2018-12-14
Trial ID
NCT03445845
Treatments Being Tested
The purpose of this study was to demonstrate efficacy including effect on i...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-08-31
Trial ID
NCT02404350
Treatments Being Tested
The purpose of the present study was to assess the efficacy of secukinumab ...
Status
Terminated
Location
Millennium Clinical Trials
Start Date
2023-08-10
Trial ID
NCT05722522
Treatments Being Tested